US Stock MarketDetailed Quotes

Johnson & Johnson (JNJ)

Watchlist
  • 242.515
  • +2.115+0.88%
Trading Mar 9 13:36 ET
584.44BMarket Cap21.99P/E (TTM)

Johnson & Johnson (JNJ) Earnings Dates, Reports & Conference Call

JNJ 2025 Q4 Earnings Dates & Summary

Overview | Medical device revenue grew by 7.5% to reach 8.8 billion dollars, while innovative drug sales increased by 10%; sales are expected to be between 100 and 101 billion dollars in 2026, surpassing expectations

Currency:USDJan 21, 2026

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
24.15B
24.56B
+415.36M
Beat Est.
+7.23%
+9.08%
+1.72%
Net Income
5.51B
5.12B
-398.87M
Miss Est.
+60.74%
+49.11%
-7.23%
Buy

Mar 9, 2026

JNJ Revenue, EPS and EBIT Estimates

Revenue

Net Profit

EPS

EBIT

Revenue is based on 13 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2026/Q2-- / 25.069B--
Apr 14, 20262026/Q1-- / 23.594B--
Jan 21, 20262025/Q424.564B / 24.149B--
Oct 14, 20252025/Q323.993B / 23.755B--
Jul 16, 20252025/Q223.743B / 22.861B--
DatePeriodRevenue/EstimateEarnings Call
--2026/Q2-- / 25.069B--
Apr 14, 20262026/Q1-- / 23.594B--
Jan 21, 20262025/Q424.564B / 24.149B
Oct 14, 20252025/Q323.993B / 23.755B--
Jul 16, 20252025/Q223.743B / 22.861B

Unlock Free Earnings Estimates

Earnings of Companies Similar to Johnson & Johnson

Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Recently, the conflict between the US and Iran has continued, with the Strait of Hormuz at a standstill. A surge in oil prices, compounded b Show More